Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® according to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypercholesterolemia Diabetes Mellitus Dyslipidemias Endocrine System Diseases Glucose Metabolism Disorders Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13496, South Korea

About this study

A Multi-center, Open-label, Observational Study

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women aged ≥19 years
Diagnosed with hypercholesterolemia
LDL-C level meets cardiovascular/cerebrovascular risk group classification
Willing to participate for 12 months
Provided written informed consent

Exclusion criteria

Contraindications to Livalozet®

Treatment and study plan

Primary outcomes

Percent change from baseline in LDL-C level at Week 24

Time frame: From enrollment to the end of treatment at 24 weeks

Sponsors and collaborators

Lead sponsor

JW Pharmaceutical

Industry

Registry information

Official study title

A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® According to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients

Acronym: VICTORY

Important dates

Study start: 2022
Primary completion: 2025
Study completion: 2025
First posted: Feb 3, 2026
Registry last updated: Feb 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed